FDA Approved: FOSAPREPITANT — Original Application (BE Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved the original application for Fosaprepitant filed by BE Pharmaceuticals Inc. (ANDA212309). Fosaprepitant is used to prevent chemotherapy-induced nau…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• FOSAPREPITANT (FOSAPREPITANT DIMEGLUMINE)

Snippet

ORIG AP for FOSAPREPITANT (FOSAPREPITANT)